Quotient Sciences Quotient Sciences

X

CAS 63095-51-2 manufacturers and suppliers on PharmaCompass

PharmaCompass
(4R)-4-propyloxolan-2-one
Also known as: 63095-51-2, Brivaracetam intermediate 1, (4r)-4-propyloxolan-2-one, 2(3h)-furanone, dihydro-4-propyl-, (r)-, Lp4ge5vl92, (r)-4-propyl-dihydrofuran-2-one
Molecular Formula
C7H12O2
Molecular Weight
128.17  g/mol
InChI Key
NVTUTJMZAZZKAZ-ZCFIWIBFSA-N
FDA UNII
LP4GE5VL92

1 2D Structure

(4R)-4-propyloxolan-2-one

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4R)-4-propyloxolan-2-one
2.1.2 InChI
InChI=1S/C7H12O2/c1-2-3-6-4-7(8)9-5-6/h6H,2-5H2,1H3/t6-/m1/s1
2.1.3 InChI Key
NVTUTJMZAZZKAZ-ZCFIWIBFSA-N
2.1.4 Canonical SMILES
CCCC1CC(=O)OC1
2.1.5 Isomeric SMILES
CCC[C@@H]1CC(=O)OC1
2.2 Other Identifiers
2.2.1 UNII
LP4GE5VL92
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 63095-51-2

2. Brivaracetam Intermediate 1

3. (4r)-4-propyloxolan-2-one

4. 2(3h)-furanone, Dihydro-4-propyl-, (r)-

5. Lp4ge5vl92

6. (r)-4-propyl-dihydrofuran-2-one

7. (r)-dihydro-4-propyl-2(3h)-furanone

8. (+)-(r)-4-propyl-4,5-dihydrofuran-2(3h)-one

9. Unii-lp4ge5vl92

10. Schembl18263291

11. Amy16477

12. Mfcd29905061

13. Zinc34596195

14. (r)-dihydro-4-propylfuran-2(3h)-one

15. S10720

16. Ac-29290

17. Ds-19249

18. Cs-0090076

19. A857888

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 128.17 g/mol
Molecular Formula C7H12O2
XLogP31.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass128.083729621 g/mol
Monoisotopic Mass128.083729621 g/mol
Topological Polar Surface Area26.3 Ų
Heavy Atom Count9
Formal Charge0
Complexity110
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
URL Supplier Web Content
63095-51-2
Brivaracetam
Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic se...
Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kimia aims to become a globally recognized company in both APIs and FDFs while upholding clean business practices. Kimia's state-of-the-art facilities at Village Bhondsi, Gurugram enable it to produce a wide range of APIs. Kimia also plans to establish its own facilities for lifestyle segments, adhering to international regulatory standards. Kimia aims to provide the best pharmaceutical products and support to consumers and healthcare professionals.
Kimia Biosciences

CPhI Japan

Not Confirmed

envelop Contact Supplier
Flag China
Digital Content Digital Content
63095-51-2
Brivaracetam
​Headquartered in Fengxian District, Shanghai Minbiotch Co., Ltd. is a company specializing in the R&D ...
​Headquartered in Fengxian District, Shanghai Minbiotch Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry.
Flag India
Digital Content Digital Content
63095-51-2
Brivaracetam
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and interme...
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates.
Aptra Synthesis

CPhI Japan

Not Confirmed

envelop Contact Supplier
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
63095-51-2
Brivaracetam
We are CDMO engaged in drug impurities research, customed synthesis for almost 10 years. In addition, we ...
We are CDMO engaged in drug impurities research, customed synthesis for almost 10 years. In addition, we establish a long-term in-depth partnerships with many worldwide pharma, especially including USP, EP, LGC, Clearsynth, etc. Our main products cover drug impurity standards, intermediates, & other pharmaceutical refs. standards with customers' desired purity. Most of our products are in stock and at a competitive price. Posaconazole key intermediates are now available for kg specification bulk quote: POS-A,CAS#149809-43-8, POS-B, CAS#184177-83-1 Sacubitril/valsartan (LCZ696) intermediate: CAS#1012341-50-2 available for a bulk quote.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
63095-51-2
Brivaracetam
Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and developmen...
Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and development, manufacturing process and sales service of pharmaceutical intermediates and APIs. It has passed ISO9001:2000 international quality management system certificate. Its business scope includes development and manufacturing of APIs and pharmaceutical intermediates, contract development and manufacturing for domestic and international pharmaceutical companies, technical consultation, service and transfer.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
63095-51-2
Brivaracetam
Based on the excellent enzymatic technology platform, Enzymaster Chemical applies innovative technology t...
Based on the excellent enzymatic technology platform, Enzymaster Chemical applies innovative technology to realize its commercial production of chiral compounds.As a wholly-owned subsidiary of Enzymaster®, we think globally and devote to supply high quality chemical products, which are sustainable supply, with eco-friendly process and competitive price.Meanwhile, we provide domestic and overseas customers biocatalytic custom synthesis serves.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
63095-51-2
Brivaracetam
Epoch-Labs is a Hyderabad, India based Research Organization that gives science administrations to expans...
Epoch-Labs is a Hyderabad, India based Research Organization that gives science administrations to expansive pharmaceutical organization, agrochemical organizations crosswise over globe to quicken their R&D programs from revelation to creation. As an exploration driven and client centered organization, Epoch-Labs administrations are intended to abbreviate the revelation and improvement time through financially savvy and productive outsourcing answers for our clients.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
63095-51-2
Brivaracetam
Shanghai Daishang Chemical Co., Ltd. established in January 2005, sticking to the guiding principle "Tech...
Shanghai Daishang Chemical Co., Ltd. established in January 2005, sticking to the guiding principle "Technical innovation, Quality Orientation", we practice best of technology innovation, optimized management and robust service system for our customers. Daishang Chem is specialized in the researching, manufacturing, sales and marketing of API & Its Intermediates as well as other Fine Chemicals, taking great advantages of professional and proficient staff, based on three chemical manufacturing sites and one GMP manufacturing workshops in Liaoning, Henan and Zhejiang provinces, and one R&D laboratory in Zhangjiang Hi-tech Park.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
63095-51-2
Brivaracetam
Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leader...
Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leadership of a “National 1000 Talents Program” expert. By leveraging its core competency in chiral synthesis, enzymatic catalysis and continuous flow micro reactor, HwaGen Pharmaceutical is dedicated to development and manufacturing of specialty and niche intermediates and APIs covering various therapeutic areas including oncology, antiviral and respiratory, delivering high value-added and affordable products for global pharmaceutical industry. Equipments for Analysis & Test include Tabletop NMR, LC-MS, GC, HPLC etc.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY